PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Koch Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.\', \'Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Division of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab623
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34245255
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all